GlaxoSmithKline PLC — Capital/Financing Update 2019

Oct 16, 2019

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0559Q

Deutsche Bank AG London

16 October 2019

16-Oct-19

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in

which such distribution would be unlawful.

GlaxoSmithKline Capital plc

Post-stabilisation Period Announcement

Further to the pre-stabilisation period announcement dated 16/09/20191 Deutsche Bank AG London (contact: DCM Syndication TA; telephone: 0207 54 54153 hereby gives notice that no stabilisation (within the meaning of Article 3.2(d) of the Market Abuse Regulation (EU/596/2014) or the rules of the Financial Conduct Authority)2 was undertaken by the Stabilisation Manager(s)3 named below in relation to the offer of the following securities.

The Securities:

Issuer:                                                                                  GlaxoSmithKline Capital plc

Guarantor (if any):                                                           GlaxoSmithKline plc

Aggregate nominal amount:                                          EUR 2.5bn

Description:                                                                        GlaxoSmithKline EUR 2y FRN and 2/4y FXD

Stabilisation Manager(s):                                                  BNPP, CS, DB, MS                           

Offer Price:                                                                         100.650 / 100.289 / 100.184

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

STACKADNFBDKOKD